In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...